COVID-19 pandemic is caused by the novel coronavirus SARS-CoV-2. Angiotensin-
converting enzyme 2 (ACE2) is not only an enzyme but also a functional receptor on cell …

Background The equality in the distribution of vaccines between and within countries along
with follow sanitation tips and observe social distance, are effective strategies to rid the …

Background: Patients critically ill with coronavirus disease-2019 (COVID-19) feature
hyperinflammation, and the associated biomarkers may be beneficial for risk stratification …

Mortality rates of coronavirus disease‐2019 (COVID‐19) continue to rise across the world.
Information regarding the predictors of mortality in patients with COVID‐19 remains scarce …

Objective Clinical and laboratory biomarkers to predict the severity of coronavirus disease
2019 (COVID-19) are essential in this pandemic situation of which resource allocation must …

For a brief moment, in the early days of COVID-19, some reports heralded the new
coronavirus, SARS-CoV-2, as a “great equalizer.” It is unlikely that any anthropologist …

Background The aim of this study is to evaluate the impact of diabetes, hypertension,
cardiovascular disease and the use of angiotensin converting enzyme inhibitors/angiotensin …

Objective We aimed to systematically identify the possible risk factors responsible for severe
cases. Methods We searched PubMed, Embase, Web of science and Cochrane Library for …

Background and aims The ongoing COVID-19 pandemic is disproportionately affecting
patients with comorbidities. Therefore, thorough comorbidities assessment can help …

Objective Risk factors for in-hospital mortality in confirmed COVID-19 patients have been
summarized in numerous meta-analyses, but it is still unclear whether they vary according to …